BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 79
New Positions 10
Increased Positions 37
Decreased Positions 25
Positions with Activity 62
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,270

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.63%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.27%
Healthcare 87.11%
Services 0%
Technology
Transportation
Utilities

37 INCREASED Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
MEDGENICS INC COM NEW 8,036 8,036 New 1,025,000
PARATEK PHARMACEUTICALS INC COM 7,608 7,608 New 260,283
TREVENA INC COM 7,595 4,361 134.86 1,409,153
AUSPEX PHARMACEUTICALS INC COM 6,724 6,724 New 100,000
ACCURAY INC COM 6,286 1,796 40 700,000
CARDICA INC COM 5,609 1 .01 8,874,992
IGNYTA INC COM 5,480 3,559 185.20 641,700
AQUINOX PHARMACEUTICALS INC COM 5,185 207 4.17 531,768
NOVADAQ TECHNOLOGIES INC COM 5,154 1,926 59.68 311,403
RECRO PHARMA INC COM 4,820 823 20.59 1,413,533
HEARTWARE INTL INC COM 4,262 4,262 New 50,000
ADMA BIOLOGICS INC COM 3,713 3,713 New 389,193
AMARIN CORP PLC SPONS ADR NEW 3,373 3,373 New 2,233,746
ONCOTHYREON INC COM 3,200 800 33.33 2,000,000
TONIX PHARMACEUTICALS HLDG COR COM NEW 2,985 1,340 81.49 501,639
MASIMO CORP COM 2,885 2,885 New 97,900
RAPTOR PHARMACEUTICAL CORP COM 144 144 New 15,558